BioAge appoints Dov Goldstein as Chief Financial Officer and Ann Neale as Chief Development Officer

RICHMOND, Calif.--(BUSINESS WIRE)-- #CDO--BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target the molecular causes of aging to extend healthy human lifespan, today announced the appointment of Dov Goldstein, M.D., M.B.A. as Chief Financial Officer (CFO) and Ann Neale as Chief Development Officer (CDO). Both officers are the first to hold their respective positions at BioAge. “We are thrilled to welcome two seasoned industry leaders into the BioAge management te